CL2015002329A1 - Selamectina para el tratamiento de las infestaciones por piojos de mar. - Google Patents

Selamectina para el tratamiento de las infestaciones por piojos de mar.

Info

Publication number
CL2015002329A1
CL2015002329A1 CL2015002329A CL2015002329A CL2015002329A1 CL 2015002329 A1 CL2015002329 A1 CL 2015002329A1 CL 2015002329 A CL2015002329 A CL 2015002329A CL 2015002329 A CL2015002329 A CL 2015002329A CL 2015002329 A1 CL2015002329 A1 CL 2015002329A1
Authority
CL
Chile
Prior art keywords
selamectin
treatment
sea lice
lice infestations
infestations
Prior art date
Application number
CL2015002329A
Other languages
English (en)
Inventor
John Adam Wendt
David Jose Asper
Stacy Ross
Original Assignee
Zoetis Services Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50238514&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2015002329(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Zoetis Services Llc filed Critical Zoetis Services Llc
Publication of CL2015002329A1 publication Critical patent/CL2015002329A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/163—Sugars; Polysaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/80—Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
    • Y02A40/80—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in fisheries management
    • Y02A40/81—Aquaculture, e.g. of fish
    • Y02A40/818—Alternative feeds for fish, e.g. in aquacultures

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Husbandry (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Insects & Arthropods (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Birds (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Fodder In General (AREA)
  • Feed For Specific Animals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Farming Of Fish And Shellfish (AREA)

Abstract

LA INVENCIÓN DESCRIBE UN PROCEDINIIENTO PARA TRATAR UNA INFECCIÓN O INFESTACIÓN PARASITARIA, EN PARTICULAR PIOJOS DE MAR, EN UN PEZ, MEDIANTE LA ADMINISTRACIÓN DE UNA CANTIDAD EFICAZ DE SELAMECTINA.
CL2015002329A 2013-02-26 2015-08-19 Selamectina para el tratamiento de las infestaciones por piojos de mar. CL2015002329A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201361769484P 2013-02-26 2013-02-26

Publications (1)

Publication Number Publication Date
CL2015002329A1 true CL2015002329A1 (es) 2016-01-08

Family

ID=50238514

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2015002329A CL2015002329A1 (es) 2013-02-26 2015-08-19 Selamectina para el tratamiento de las infestaciones por piojos de mar.

Country Status (14)

Country Link
US (1) US10765657B2 (es)
EP (1) EP2961413B1 (es)
CN (1) CN105101973A (es)
AR (1) AR094882A1 (es)
AU (1) AU2014223626A1 (es)
BR (1) BR112015020342A2 (es)
CA (1) CA2900950C (es)
CL (1) CL2015002329A1 (es)
DK (1) DK2961413T3 (es)
HK (1) HK1215676A1 (es)
NZ (1) NZ710522A (es)
PE (1) PE20151753A1 (es)
RU (1) RU2015133445A (es)
WO (1) WO2014134101A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2560882A (en) * 2017-03-15 2018-10-03 Preston Innovations Ltd Fish bait additive

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5015630A (en) 1989-01-19 1991-05-14 Merck & Co., Inc. 5-oxime avermectin derivatives
GB9024928D0 (en) * 1990-11-16 1991-01-02 Beecham Group Plc Novel treatment
GB9300883D0 (en) 1993-01-18 1993-03-10 Pfizer Ltd Antiparasitic agents
US5981500A (en) 1994-01-12 1999-11-09 Pfizer Inc. Antiparasitic agents related to the milbemycins and avermectins
GB9825402D0 (en) 1998-11-19 1999-01-13 Pfizer Ltd Antiparasitic formulations
US6486128B1 (en) * 1999-04-08 2002-11-26 Schering-Plough Veterinary Corporation Method of using emamectin to treat fish parasites
US6538031B1 (en) 1999-11-25 2003-03-25 Novartis Animal Health Us, Inc. Method of controlling sea lice infestation in fish
JP5101508B2 (ja) 2005-08-29 2012-12-19 ノバルティス アーゲー 魚寄生虫制御のためのオキサゾール誘導体の使用
EP1849363A1 (en) * 2006-03-09 2007-10-31 Cheminova A/S Synergistic combination of glutamate- and GABA-gated chloride agonist pesticide and at least one of Vitamin E or Niacin
BRPI0705822A2 (pt) * 2007-10-25 2009-06-23 Schering Plough Saude Animal Ltda formulação injetável com ação prolongada e uso de um agente semi-sintético derivado do grupo das avermectinas, em combinação com um polìmero biodegradável
EP2601190B1 (en) 2010-08-05 2018-07-04 Zoetis Services LLC Isoxazoline derivatives as antiparasitic agents
CN102406074A (zh) * 2011-11-18 2012-04-11 大连兆阳软件科技有限公司 一种鱼饲料

Also Published As

Publication number Publication date
WO2014134101A1 (en) 2014-09-04
CN105101973A (zh) 2015-11-25
NZ710522A (en) 2016-05-27
CA2900950C (en) 2017-06-27
PE20151753A1 (es) 2015-12-02
RU2015133445A (ru) 2017-03-31
US10765657B2 (en) 2020-09-08
CA2900950A1 (en) 2014-09-04
EP2961413A1 (en) 2016-01-06
AR094882A1 (es) 2015-09-02
BR112015020342A2 (pt) 2017-07-18
US20150366837A1 (en) 2015-12-24
AU2014223626A1 (en) 2015-08-20
HK1215676A1 (zh) 2016-09-09
EP2961413B1 (en) 2020-08-05
DK2961413T3 (da) 2020-09-07

Similar Documents

Publication Publication Date Title
CY1121701T1 (el) Οργανικες ενωσεις μονοβακταμης για την αντιμετωπιση βακτηριακων λοιμωξεων
CL2015002744A1 (es) Alimento para peces que comprende azadiractina, útil para el tratamiento y/o prevención de infecciones y/o infestaciones parasitarias, particularmente contra el piojo de mar lepeophtherius salmonis.
DK3174868T3 (da) Forbindelser, der er aktive mod bromodomæner
CO6821938A2 (es) Un compuesto de guanidina o una sal del mismo para el tratamiento de enfermedades relacionadas con vap -1
GT201600198A (es) Combinaciones de principios activos insecticidas y nematocidas
CL2018001744A1 (es) Compuestos depsipeptídicos como anthelmínticos
CL2015003483A1 (es) Composiciones que comprenden tintes fotocrómicos para el tratamiento de superficies.
CL2016002164A1 (es) Composición agroquímica para el tratamiento de follaje
UY34750A (es) ?compuestos para el tratamiento del hiv, composiciones,métodos de preparación, intermediarios y métodos terapéuticos?.
EA201792006A1 (ru) Антимикробные соединения и способы их получения и их применение
DK3513809T3 (da) Medicinsk sammensætning, som omfatter tivozanib
CL2015003059A1 (es) Empaque para tratamiento antimicrobiano de plantas.
PH12016500356A1 (en) Nsaid and sigma receptor ligand combinations
CL2016002337A1 (es) Uso de derivados de trifluoroetilsulfóxido sustituidos con n-arilamidina para combatir parásitos mediante riego, aplicación por goteo, aplicación por inmersión, inyección en el suelo o mediante el tratamiento de semillas
BR112017002318A2 (pt) combinações de fármacos para tratar mieloma múltiplo.
BR112017013156A2 (pt) combinações de composto ativo.
CL2018001502A1 (es) Procedimiento para el tratamiento de efluente acuoso.
BR112017012801A2 (pt) combinações de composto ativo.
MA43052A (fr) Inhibiteurs de la kallicréine plasmatique humaine
EA201790687A1 (ru) Хинолинкарбоксамиды для применения в лечении множественной миеломы
CL2018001719A1 (es) Tratamiento contra el mieloma múltiple (divisional solicitud 201600396)
BR112015016033A8 (pt) composições farmacêuticas para tratamento de infecções por bactérias, e seus usos
CL2015003663A1 (es) Compuestos de pirimidinio sustituidos y derivados para combatir plagas animales.
CL2015002612A1 (es) Oligonucletotidos antisentido para el tratamiento de células madre del cáncer.
BR112016010635A2 (pt) composto para tratamento de hipoglicemia severa